Vision

First Swiss Liquid Biopsy to detect various cancers at lowest efficient costs and within shortest time.

Today, diagnostics for the most prominent cancer types are not qualified enough. Time and money consuming cascades of several diagnostic methods have to be applied. Therefore, 4D Lifetec invested in the development of an innovative cost-efficient and easy to apply 4D Lifetest™ Liquid Biopsy.

 

With a few drops of patient’s blood, 4D Lifetest™ eradicates unclear or false positive results deriving from existing diagnostic methods within shortest time. Thus, 4D Lifetest™ will contribute efficiently to the verification of primary diagnostic of various types of cancer.

The patented 4D Lifetest™ is just before approval for the CE market. Based on today’s data, 4D Lifetest™ shows the potential to detect any kind of cancer within a few drops of blood already at its earliest stage. Therefore 4D Lifetest™ in the future has also the potential to become a reliable and feasible diagnostic method for cancer screening in general.

 

A dedicated Management Team supported by Key Experts

4D Lifetec AG is a highly innovative Swiss start up founded 2014 by Dr. Arne Faisst and Nick Mijnssen. We have set up an experienced motivated team of experts to create a footprint in the world of cancer diagnostics. Reaching today’s status, 4D Lifetec AG needs more hands to maintain dynamics and consolidate processes and services with our partners, suppliers and customers. A scientific board is currently institutionalized and expanded.

Team

  • Exec. MBA at State University at Albany, New York
  • PhD in Virology at University of Göttingen
  • MSc in Biochemistry at University of Göttingen
  • Active in the Medtech Industry since 1989 (Fresenius, Synthes, Mathys, Cendres+Métaux) in various national and international positions in Germany, France, US, Netherlands and Switzerland
  • Long term experience in the field of Life Science (Biochemistry, Molecular Cell Biology and Virology)
  • 8 years CEO and Member of Board of Directors of the Mathys Group.
  • Since 2013 owner and CEO of anfass Life Technologies AG, family office and service provider for Active Trust Management
  • Experienced manager with deep understanding of healthcare markets in Europe, Asia and the US

 

  • Exec. MBA at Lorange Institute of Business, Zurich and University of Wales, Cardiff
  • PhD in Technical Mineralogy at University of Berne
  • MSc in Mineralogy at University of Berne
  • Active in the Medtech Industry (Synthes, Mathys, Heraeus) since 2001 in various national and international positions

  • Experienced global executive with broad and deep understanding of healthcare markets and working experience from Science to Sales

  • Since 2014 engaged in active trust management at anfass Life Technologies AG

  • Since 2006 Member of Executive Committee and Treasurer of Swiss Society for Biomaterials and Regenerative Medicine

 

  • Exec. MBA at China Europe International Business School
  • MBA at Lorange Institute of Business, Zurich
  • PhD in Biochemistry at University of Zurich
  • Dipl. Ing. in Chemistry at TU Darmstadt
  • Active in Life science and Laboratory automation since 2007 in various positions
  • Extensive international project management experiences in laboratory automation and life science
  • PhD Genetics, Master in Cellular & Molecular Biology
  • CAS in Clinical research planning and conduct (Including; Ethics, basics in Swissmedic and EMEA)
  • Active in the science of molecular oncology, biomarker development and stem cell biology
  • Experienced in project management and clinical data management
  • CAS in Digital Transformation and Marketing 
  • Marketing Manager with Swiss Federal Certificate and several years of experience in marketing management
  • Specific focus on digital marketing projects and programs from her time working for a interactive marketing agency
  • Experienced in the field of insurance companies and in the sector of Life Science
  • Long time experience in organisation and administration of back office solutions at different levels and industries

Board Member

  • Exec. MBA at State University at Albany, New York
  • PhD in Virology at University of Göttingen
  • MSc in Biochemistry at University of Göttingen
  • Active in the Medtech Industry since 1989 (Fresenius, Synthes, Mathys, Cendres+Métaux) in various national and international positions in Germany, France, US, Netherlands and Switzerland
  • Long term experience in the field of Life Science (Biochemistry, Molecular Cell Biology and Virology)
  • 8 years CEO and Member of Board of Directors of the Mathys Group.
  • Since 2013 owner and CEO of anfass Life Technologies AG, family office and service provider for Active Trust Management
  • Experienced manager with deep understanding of healthcare markets in Europe, Asia and the US

Scientific Advisors

  • Senior Physician & Oncologist
  • Department of Radiation Oncology
  • Universitätsklinikum Freiburg i.B.

Contact

4D Lifetec AG
Gewerbestrasse 8
6330 Cham
Switzerland


info@4dlifetec.com
Phone +41 41 747 25 52

 

Xing

LinkedIn

Partners

empa logo 300pxCentre de Recherches en Canérologie ToulouseUniversité Toulouse

Inserm Science Health

 

 

 

 

 

 

University of Leicester